Latest Metamark Genetics Inc. Stories
New Prognostic Biopsy Test Is Designed To Guide Individual Treatment Decisions About Prostate Cancer CAMBRIDGE, Mass., May 6, 2014 /PRNewswire/ -- Metamark Genetics, Inc.
Novel Prognostic Test Is Designed to Guide Optimal Decision-Making at Diagnosis CAMBRIDGE, Mass., Feb. 27, 2014 /PRNewswire/ -- Metamark Genetics, Inc.
Experienced biotech financial manager and former investment banker joins executive team as Metamark prepares for ProMark(TM)commercialization CAMBRIDGE, Mass., Jan.
CAMBRIDGE, Mass., July 11, 2011 /PRNewswire/ -- Metamark Genetics, Inc., a privately-held oncology-focused molecular diagnostics company, today announced results from a melanoma study published in Cancer Cell.
- A volcanic mudflow.